131 related articles for article (PubMed ID: 19130904)
1. Simvastatin attenuates leukocyte recruitment in experimental bacterial meningitis.
Winkler F; Angele B; Pfister HW; Koedel U
Int Immunopharmacol; 2009 Mar; 9(3):371-4. PubMed ID: 19130904
[TBL] [Abstract][Full Text] [Related]
2. Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis.
Brandt CT; Lundgren JD; Frimodt-Møller N; Christensen T; Benfield T; Espersen F; Hougaard DM; Ostergaard C
J Neuroimmunol; 2005 Sep; 166(1-2):126-31. PubMed ID: 15982752
[TBL] [Abstract][Full Text] [Related]
3. Experimental studies of pneumococcal meningitis.
Brandt CT
Dan Med Bull; 2010 Jan; 57(1):B4119. PubMed ID: 20175949
[TBL] [Abstract][Full Text] [Related]
4. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis.
Koedel U; Bernatowicz A; Frei K; Fontana A; Pfister HW
J Immunol; 1996 Dec; 157(11):5185-91. PubMed ID: 8943431
[TBL] [Abstract][Full Text] [Related]
5. Peripheral injection of lipopolysaccharide prevents brain recruitment of leukocytes induced by central injection of interleukin-1.
Ching S; Zhang H; Lai W; Quan N
Neuroscience; 2006; 137(2):717-26. PubMed ID: 16360283
[TBL] [Abstract][Full Text] [Related]
6. A kinetic study of the cytokine/chemokines levels and disruption of blood-brain barrier in infant rats after pneumococcal meningitis.
Barichello T; Pereira JS; Savi GD; Generoso JS; Cipriano AL; Silvestre C; Petronilho F; Dal-Pizzol F; Vilela MC; Teixeira AL
J Neuroimmunol; 2011 Apr; 233(1-2):12-7. PubMed ID: 21109308
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway.
Chen G; Zhang S; Shi J; Ai J; Qi M; Hang C
Exp Neurol; 2009 Apr; 216(2):398-406. PubMed ID: 19166837
[TBL] [Abstract][Full Text] [Related]
8. Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice.
Erkkilä L; Jauhiainen M; Laitinen K; Haasio K; Tiirola T; Saikku P; Leinonen M
Antimicrob Agents Chemother; 2005 Sep; 49(9):3959-62. PubMed ID: 16127082
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte and bacterial interrelationships in experimental meningitis.
Giampaolo C; Scheld M; Boyd J; Savory J; Sande M; Wills M
Ann Neurol; 1981 Apr; 9(4):328-33. PubMed ID: 7224597
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic interference with NF-kappaB activation attenuates central nervous system complications in experimental Pneumococcal meningitis.
Koedel U; Bayerlein I; Paul R; Sporer B; Pfister HW
J Infect Dis; 2000 Nov; 182(5):1437-45. PubMed ID: 11023466
[TBL] [Abstract][Full Text] [Related]
11. Bone protective effect of simvastatin in experimental arthritis.
Funk JL; Chen J; Downey KJ; Clark RA
J Rheumatol; 2008 Jun; 35(6):1083-91. PubMed ID: 18464303
[TBL] [Abstract][Full Text] [Related]
12. Attenuated cerebrospinal fluid leukocyte count and sepsis in adults with pneumococcal meningitis: a prospective cohort study.
Weisfelt M; van de Beek D; Spanjaard L; Reitsma JB; de Gans J
BMC Infect Dis; 2006 Oct; 6():149. PubMed ID: 17038166
[TBL] [Abstract][Full Text] [Related]
13. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis.
Lutsar I; Friedland IR; Jafri HS; Wubbel L; Ahmed A; Trujillo M; McCoig CC; McCracken GH
J Antimicrob Chemother; 2003 Oct; 52(4):651-5. PubMed ID: 12951330
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin protects against multiple low-dose streptozotocin-induced type 1 diabetes in CD-1 mice and recurrence of disease in nonobese diabetic mice.
Rydgren T; Vaarala O; Sandler S
J Pharmacol Exp Ther; 2007 Oct; 323(1):180-5. PubMed ID: 17636011
[TBL] [Abstract][Full Text] [Related]
16. [Protective effect of dexamethasone and phenytoin in the treatment of experimental pneumococcal meningitis].
Martos A; Cabellos C; Martínez-Lacasa J; Viladrich PF; Gudiol F
Enferm Infecc Microbiol Clin; 1995 Mar; 13(3):146-50. PubMed ID: 7734493
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid prognostic indices in experimental pneumococcal meningitis.
Scheld WM; Giampaolo C; Boyd J; Savory J; Wills MR; Sande MA
J Lab Clin Med; 1982 Aug; 100(2):218-29. PubMed ID: 7097108
[TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier dysfunction occurring in mice infected with Angiostrongylus cantonensis.
Lee JD; Tsai LY; Chen CH; Wang JJ; Hsiao JK; Yen CM
Acta Trop; 2006 Feb; 97(2):204-11. PubMed ID: 16332352
[TBL] [Abstract][Full Text] [Related]
19. Impact of bacteremia on the pathogenesis of experimental pneumococcal meningitis.
Brandt CT; Holm D; Liptrot M; Ostergaard C; Lundgren JD; Frimodt-Møller N; Skovsted IC; Rowland IJ
J Infect Dis; 2008 Jan; 197(2):235-44. PubMed ID: 18173365
[TBL] [Abstract][Full Text] [Related]
20. Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis.
Kastenbauer S; Koedel U; Pfister HW
J Infect Dis; 1999 Oct; 180(4):1164-70. PubMed ID: 10479144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
